BioSyent Inc., a biotechnology company based in Mississauga, Ontario, has announced its participation in the upcoming Planet MicroCap investor conference in Toronto. The conference is set to take place from October 27th to October 29th, 2026, at Arcadian Court & Loft. René Goehrum, the company's President and CEO, is expected to present on October 27th, providing insights into the company's current projects and future plans.
Similarly, PharmaCorp RX Inc., a pharmacy acquisition and ownership platform headquartered in Saskatoon, Saskatchewan, will also be presenting at the conference. The company has confirmed that its senior management team will take the stage on October 28th at 5:30 P.M. Eastern Time to discuss their business model and growth strategies.
The Planet MicroCap Conference serves as a platform for small-cap companies to connect with potential investors and stakeholders, with a focus on the latest developments in the micro-cap investment space. The participation of both BioSyent and PharmaCorp highlights the growing interest in the Canadian biotechnology and pharmaceutical sectors, providing opportunities for networking and investment in these fields.
Analyzed Canadian Outlets (2)
2 headlines